Abortion clinics are preparing to administer just one pill, misoprostol, to terminate pregnancies if a federal judge’s ruling goes into effect suspending the Food and Drug Administration’s approval of mifepristone, the other drug used in a medication abortion. U.S. District Judge Matthew Kacsmaryk ruled Friday in Texas that the FDA ignored safety concerns and did not follow proper protocol when it approved mifepristone in 2000. But he gave the Biden administration a week to appeal his decision before his mandated pause on distributing the drug goes into effect. (Bendix and Lovelace, 4/10)
KHN (Kaiser Health News) is a national newsroom that produces in-depth journalism about health issues. Together with Policy Analysis and Polling, KHN is one of the three major operating programs at KFF (Kaiser Family Foundation). KFF is an endowed nonprofit organization providing information on health issues to the nation.
USE OUR CONTENT
This story can be republished for free (details).